"Antiparasitic Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs used to treat or prevent parasitic infections.
| Descriptor ID |
D000977
|
| MeSH Number(s) |
D27.505.954.122.250
|
| Concept/Terms |
Antiparasitic Agents- Antiparasitic Agents
- Agents, Antiparasitic
- Antiparasitic Drugs
- Drugs, Antiparasitic
- Parasiticides
- Antiparasitics
|
Below are MeSH descriptors whose meaning is more general than "Antiparasitic Agents".
Below are MeSH descriptors whose meaning is more specific than "Antiparasitic Agents".
This graph shows the total number of publications written about "Antiparasitic Agents" by people in this website by year, and whether "Antiparasitic Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 1 | 1 | 2 |
| 2008 | 0 | 1 | 1 |
| 2010 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 0 | 1 | 1 |
| 2017 | 7 | 6 | 13 |
| 2018 | 6 | 5 | 11 |
| 2019 | 3 | 2 | 5 |
| 2020 | 1 | 4 | 5 |
| 2021 | 4 | 3 | 7 |
To return to the timeline, click here.
Below are the most recent publications written about "Antiparasitic Agents" by people in Profiles.
-
Pitfalls in Reporting Sample Size Calculation Across Randomized Controlled Trials Involving Ivermectin for the treatment of COVID-19. Am J Ther. 2021 08 06; 28(5):e616-e619.
-
Flawed ivermectin preprint highlights challenges of COVID drug studies. Nature. 2021 08; 596(7871):173-174.
-
Ivermectin for preventing and treating COVID-19. Cochrane Database Syst Rev. 2021 07 28; 7:CD015017.
-
Ivermectin in the management of a scabies outbreak in a long-term care facility. Br J Dermatol. 2021 10; 185(4):868.
-
Ivermectin and mortality in patients with COVID-19: A systematic review, meta-analysis, and meta-regression of randomized controlled trials. Diabetes Metab Syndr. 2021 Jul-Aug; 15(4):102186.
-
Ivermectin in dermatology: why it 'mite' be useless against COVID-19. Clin Exp Dermatol. 2021 Oct; 46(7):1327-1328.
-
Zinc supplementation augments the suppressive effects of repurposed NF-?B inhibitors on ACE2 expression in human lung cell lines. Life Sci. 2021 Sep 01; 280:119752.
-
Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19. Am J Ther. 2021 04 22; 28(3):e299-e318.
-
The association between the use of ivermectin and mortality in patients with COVID-19: a meta-analysis. Pharmacol Rep. 2021 Oct; 73(5):1473-1479.
-
The Common Cichory (Cichorium intybus L.) as a Source of Extracts with Health-Promoting Properties-A Review. Molecules. 2021 Mar 23; 26(6).